BioSpecifics Technologies Corp.
Edit Page
Report
Scan day: 05 February 2014 UTC
11
Virus safety - good
Description: Produces and licenses collagenase, used as a topical treatment of dermal ulcers such as bedsores and burns. Includes explanation of therapy, investor data and profile of company based in Lynbrook, New York. (Nasdaq: BSTC)
BioSpecifics Technologies Corp. Originators in the development of injectable collagenase Consistent profitability and strong Intellectual Property portfolio. XIAFLEX® is currently marketed in the U.S. for Dupuytren's contracture and Peyronie's disease.
Size: 263 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | BioSpecifics Technologies Corp. |
| Keywords: | BioSpecifics Technologies Corp.,Originators in the development of injectable collagenase |
| Description: | BioSpecifics Technologies Corp. - Originators in the development of injectable collagenase. |
| IP-address: | 173.236.145.150 |
WHOIS Info
| NS | Name Server: NS19A.NAMESERVERS.NET Name Server: NS19B.NAMESERVERS.NET |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 13-nov-1996 Expiration Date: 12-nov-2015 |